These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
24. Success in an uneven market. Russo E Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372 [No Abstract] [Full Text] [Related]
25. The promise of South African biotech. Akermann B; Kermani F Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404 [No Abstract] [Full Text] [Related]
28. [Session 1. Is biotechnologies a laboratory for academic capitalism]. Orsi F Med Sci (Paris); 2012; 28 Spec No 2():9-10. PubMed ID: 22759888 [No Abstract] [Full Text] [Related]
29. Economics: age, health and wealth. Cairncross F Nature; 2007 Aug; 448(7156):875-6. PubMed ID: 17713520 [No Abstract] [Full Text] [Related]
30. Managing your compensation expectations in today's environment: a third look. Radford J Nat Biotechnol; 2005 Dec; 23(12):1569-70. PubMed ID: 16333298 [TBL] [Abstract][Full Text] [Related]
31. Nanotechnology in biology: big collaborations for a small world. Blow N Nat Methods; 2008 Jun; 5(6):569-74. PubMed ID: 18511920 [No Abstract] [Full Text] [Related]
32. Biomedical science: Houston has lift-off. Smaglik P Nature; 2014 Aug; 512(7514):339-40. PubMed ID: 25147885 [No Abstract] [Full Text] [Related]
33. In focus: biointerphase science in Singapore. Liedberg B; Knoll W Biointerphases; 2010 Sep; 5(3):FA1. PubMed ID: 21171702 [No Abstract] [Full Text] [Related]
34. Primed for a biotech boom. Cyranoski D Nature; 2005 Oct; 437(7061):1060-2. PubMed ID: 16231417 [No Abstract] [Full Text] [Related]